Ogier advises WORK Medical Technology Group LTD on Nasdaq IPO

Ogier's Corporate teams in the Cayman Islands and Hong Kong have advised China-based WORK Medical Technology Group LTD on its US$8 million initial public offering on Nasdaq.

WORK Medical Technology Group LTD is a supplier of medical devices in the People's Republic of China (PRC). The ordinary shares began trading on 23 August 2024 under the ticker symbol WOK. The initial public offering (IPO) closed on 26 August. 

The Ogier team providing Cayman counsel was led by partner Bradley Kruger, with support from senior associate Laura O'Byrne and associate Mike Azarnikow. They worked alongside US counsel Hunter Taubman Fischer & Li. The team in Hong Kong, led by partner Cecilia Li, assisted the company to complete the filing procedures with the China Securities Regulatory Commission pursuant to the Trial Administrative Measures of Overseas Securities Offering and Listing by Domestic Companies in China. They worked alongside PRC counsel Jingtian & Gongcheng. Kingswood Capital Partners LLC was the sole book running manager for the offering and was advised by Ortoli Rosenstadt LLP.

Bradley said: "Our corporate experts in Cayman and Hong Kong have considerable expertise advising companies on US IPOs, particularly Chinese companies looking to go public in the US, as well as special purpose acquisition companies (SPACs). With our colleagues in Hong Kong, we were able to provide seamless expertise, particularly in relation to Chinese regulators, and we're delighted to have assisted our client on this successful transaction."